NOVAVAX
Bookmark
ShareNOVAVAX is a company. It is located in Gaithersburg, the United States and was founded in 1987. The company is part of the Health Care sector, specifically in the Biotechnology industry.
Key facts
- city: Gaithersburg
- state: MD
- country: United States
- sector: Health Care
- industry: Biotechnology
- foundation year: 1987
- CEO: Stanley Charles Erck
- CEO gender: Male
Classified as: organization
Business
NOVAVAX is one of the companies in the United States, companies in Biotechnology, companies in Health Care and 3,550,070 companies in our database.
- Assets: 2.6B $
- Debt: 538.6M $
- Employees: 1,541 people
- Free cash flow: -509246020 $
- Market cap: 2.3B $
- Profits: -1743750000 $
- Revenues: 1.4B $
Stocks from NOVAVAX:
Talking Points
- New Era of Revolutionary Vaccines
- Meet innovative vaccine technology from Novavax. Our biotech company prevents a broad range of infectious diseases through recombinant nanoparticle technology.
- Producing next-generation vaccines with global access for more people. See what’s developing at https://t.co/apuZo0qpnM.
- Producing next-generation vaccines with global access for more people. ... Jobs at NOVAVAX INC Manager, Biostatistics ... CureVac Biotechnology Tübingen, Baden-Württemberg Johnson & Johnson Hospital & Health Care ...
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Learn more about talking points
